For: | Abunada A, Sirhan Z, Thyagarajan A, Sahu RP. Tyrosine kinase inhibitors and human epidermal growth factor receptor-2 positive breast cancer. World J Clin Oncol 2023; 14(5): 198-202 [PMID: 37275938 DOI: 10.5306/wjco.v14.i5.198] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v14/i5/198.htm |
Number | Citing Articles |
1 |
Shujuan Ma. Application and challenge of HER2DX genomic assay in HER2+ breast cancer treatment. American Journal of Cancer Research 2024; 14(9): 4218 doi: 10.62347/JWHA6355
|
2 |
Xuening Liu, Xiaoyue Zhang, Rui Feng, Xiang Ren, Dan Wu, Xuejing Liu, Lei Liu, Qin Wei. Microfluidic Immunosensor Platform for Sensitive Detection of Human Epidermal Growth Factor Receptor-2 Based on Enhanced Cathode Electrochemiluminescence of Bimetallic Nanoclusters. Analytical Chemistry 2024; 96(21): 8390 doi: 10.1021/acs.analchem.3c05561
|
3 |
Elena Gurrieri, Giulia Carradori, Michela Roccuzzo, Michael Pancher, Daniele Peroni, Romina Belli, Caterina Trevisan, Michela Notarangelo, Wen-Qiu Huang, Agata S. A. Carreira, Alessandro Quattrone, Guido Jenster, Timo L. M. Ten Hagen, Vito Giuseppe D’Agostino. CD81-guided heterologous EVs present heterogeneous interactions with breast cancer cells. Journal of Biomedical Science 2024; 31(1) doi: 10.1186/s12929-024-01084-9
|